Sep 12, 2013
Ceftazidime/avibactam Combination Receives Qualified Infectious...
The QIDP designation was created by the Generating Antibiotic Incentives Now Act, which was part of the FDA Safety and Innovation Act , which was signed into law in 2012.
Cefepime: A Review of its Use in the Management of Hospitalized Patients with Pneumonia
Cefepime , Maxcef, Cepimax, Cepimex, Axepim, a parenteral fourth-generation cephalosporin, is active against many organisms causative in pneumonia.
Fedora Pharmaceuticals Unveils Details of Antibiotic Resistance...
Fedora Pharmaceuticals, Inc. today announced that the Company and its collaborators will be presenting 10 posters at the upcoming Interscience Conference on Antimicrobial Agents and Chemotherapy .